Mounjaro®
Starting from £179.99/mo
Start journey Learn moreFeeling cold on Mounjaro is something a number of people notice, and it is worth understanding why. Cold sensations and feeling chilly are not listed among tirzepatide's common side effects in the UK SmPC, yet the experience is real and has a plausible explanation rooted in how the medicine works. Mounjaro is a prescription-only medicine; a GPhC-registered prescriber reviews every consultation before treatment begins, and any new or persistent symptoms are always worth raising with your clinical team.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
There is a widespread assumption, shared in weight-loss forums and social media threads, that Mounjaro directly "slows metabolism" or suppresses thyroid function, causing coldness as a drug side effect in the same way nausea or indigestion might. That version of events does not hold up. The NHS tirzepatide medicine page lists the recognised common and uncommon side effects; cold intolerance and abnormal temperature sensation are not among them. Tirzepatide is not known to act on thyroid hormone output in humans, and there is no established direct pharmacological pathway that explains coldness as a standalone effect of the drug itself.
That does not mean the experience is imagined. It means the cause sits one step back: in what Mounjaro does to your appetite, your calorie intake, and your body composition over weeks and months.
When Mounjaro suppresses appetite effectively, most people eat considerably less. A meaningful calorie deficit over several weeks lowers basal metabolic rate to some degree, which means your body produces less heat at rest. Fat tissue also acts as insulation; as subcutaneous fat decreases, less of that insulation is available to keep you warm. Both effects are well-documented consequences of sustained weight loss, regardless of how that weight loss is achieved.
For some people the change is subtle. Others describe feeling the cold more sharply than they did before, particularly in cooler rooms or outdoors. This tends to be most noticeable during the active weight-loss phase. It is one of several body-composition changes worth being aware of when considering Mounjaro for weight management.
A practical side of this worth knowing: maintaining adequate protein intake and staying well hydrated both support metabolic function during treatment. Resistance exercise helps preserve muscle mass, which generates more heat than fat tissue. None of that replaces clinical advice, but it gives the experience some useful context.
Cold extremities are slightly different from general cold intolerance and are worth treating as their own question. Some people on tirzepatide report specifically cold feet rather than whole-body chilliness. Several explanations are possible here: reduced peripheral circulation during a period of significant metabolic change, less insulating fat around the feet and ankles, or in some individuals dehydration from gastrointestinal side effects reducing blood volume slightly.
Pre-existing conditions such as Raynaud's phenomenon or anaemia can also produce cold extremities and may become more noticeable during the demands of active weight loss. If you have a history of either, mention it to your prescriber. A broader question some readers arrive with is whether Mounjaro might be connected to more complex neurological symptoms; the evidence on that is examined separately, including a look at whether tirzepatide has any link to MS-type symptoms.
Persistent or painful cold in the hands or feet, colour changes in the skin, or numbness that does not resolve quickly are all reasons to seek advice from a GP or your prescribing team rather than waiting for the next scheduled review.
Most people who notice feeling colder on Mounjaro are experiencing a secondary effect of eating less and losing weight. It passes or stabilises as the body adjusts and weight loss slows. The MHRA's Yellow Card scheme exists for reporting unexpected or persistent side effects; if something concerns you, logging it there contributes to ongoing medicines safety monitoring in the UK.
If the cold sensation is accompanied by fatigue, hair thinning, constipation, or very slow heart rate, those symptoms together point toward a thyroid check rather than Mounjaro specifically; your GP can arrange that. Severe shivering or cold alongside dizziness and nausea from not eating enough is a sign to eat something and contact your prescriber. For a fuller picture of what the evidence does and does not link to tirzepatide, the overview of reported Mounjaro effects covers a wider range of queries patients bring to us.
Cost sometimes comes up when people are managing symptoms and wondering whether to continue treatment. A straightforward Mounjaro price comparison for the UK sets out what to look for in a provider quote. And if you have questions about accessing treatment without a lengthy referral process, the Mounjaro without a GP referral page explains how private prescribing works.
If any symptom is giving you pause, a conversation with a prescriber is the most direct route to a clear answer. Speak to our prescribers through a free consultation, reviewed the same day by a named GPhC-registered clinician.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.